Status:
COMPLETED
Evaluation of Vascular Pathology With 3D, Time-Resolved Phase Contrast Magnetic Resonance Imaging (MRI)
Lead Sponsor:
University of California, San Francisco
Conditions:
Healthy
Eligibility:
All Genders
1+ years
Brief Summary
Aortic coarctation is a relatively common cardiovascular condition with high associated mortality if not treated. Even with successful repair, however, close follow up is needed as late complications ...
Eligibility Criteria
Inclusion
- Patients: primarily status post intervention for repair of aortic coarctation and undergoing routine MRI follow up, but also adult patients with other vascular pathologies undergoing routine MRI evaluation, who may be good candidates for 4D Flow blood flow analysis.
- Healthy subjects: healthy members of the radiology residency program and staff at UCSF.
Exclusion
- Anyone else.
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00722904
Start Date
June 1 2007
End Date
September 1 2010
Last Update
October 8 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Medical Center
San Francisco, California, United States, 94143